These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

791 related items for PubMed ID: 22873183

  • 1. Maintenance medication for opiate addiction: the foundation of recovery.
    Bart G.
    J Addict Dis; 2012; 31(3):207-25. PubMed ID: 22873183
    [Abstract] [Full Text] [Related]

  • 2. Adjunctive memantine for opioid use disorder treatment: A systematic review.
    Elias AM, Pepin MJ, Brown JN.
    J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
    [Abstract] [Full Text] [Related]

  • 3. Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder.
    Fipps DC, Oesterle TS, Kolla BP.
    Semin Neurol; 2024 Aug; 44(4):441-451. PubMed ID: 38848746
    [Abstract] [Full Text] [Related]

  • 4. Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
    Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.
    Curr Drug Abuse Rev; 2012 Mar; 5(1):52-63. PubMed ID: 22280332
    [Abstract] [Full Text] [Related]

  • 5. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV, Katz E, Weitz B, Visconti K.
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [Abstract] [Full Text] [Related]

  • 6. Medications for management of opioid use disorder.
    Koehl JL, Zimmerman DE, Bridgeman PJ.
    Am J Health Syst Pharm; 2019 Jul 18; 76(15):1097-1103. PubMed ID: 31361869
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical treatment of opioid addiction and dependence.
    Ling W, Rawson RA, Compton M.
    Methods Mol Med; 2003 Jul 18; 84():285-95. PubMed ID: 12703332
    [No Abstract] [Full Text] [Related]

  • 9. CE: Acute Pain Management for People with Opioid Use Disorder.
    Broglio K, Matzo M.
    Am J Nurs; 2018 Oct 18; 118(10):30-38. PubMed ID: 30211703
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ.
    Pharmacotherapy; 2017 Jul 18; 37(7):824-839. PubMed ID: 28543191
    [Abstract] [Full Text] [Related]

  • 12. Medication Treatment of Opioid Use Disorder.
    Bell J, Strang J.
    Biol Psychiatry; 2020 Jan 01; 87(1):82-88. PubMed ID: 31420089
    [Abstract] [Full Text] [Related]

  • 13. Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence.
    Jackson H, Mandell K, Johnson K, Chatterjee D, Vanness DJ.
    Subst Abus; 2015 Jan 01; 36(2):226-31. PubMed ID: 25775099
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
    Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G.
    Am J Drug Alcohol Abuse; 2012 May 01; 38(3):187-99. PubMed ID: 22404717
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL, Andraka-Christou B, Attermann J, Cupito A, Buche J, Beck AJ.
    Subst Abuse Treat Prev Policy; 2020 Sep 14; 15(1):69. PubMed ID: 32928272
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.